Yield10 Bioscience, Inc.
YTENQ
$0.015
$0.000.00%
| Weiss Ratings | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.11 | |||
| Price History | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -94.64% | |||
| 90-Day Total Return | -97.72% | |||
| Year to Date Total Return | -95.71% | |||
| 1-Year Total Return | -99.80% | |||
| 2-Year Total Return | -99.98% | |||
| 3-Year Total Return | -99.99% | |||
| 5-Year Total Return | -99.98% | |||
| 52-Week High % Change | -99.85% | |||
| 52-Week Low % Change | 1,400.00% | |||
| Price | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.84 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jan 16, 2025 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.02K | |||
| Enterprise Value | 2.04M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -26.30 | |||
| Earnings Per Share Growth | -60.52% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.01 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 2.72 | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -0.17 | |||
| Enterprise Value/EBIT | -0.16 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 642.40K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617 583 1700 | |||
| Address | 19 Presidential Way Woburn, MA 01801 | |||
| Website | www.yield10bio.com | |||
| Country | United States | |||
| Year Founded | 1992 | |||
| Profitability | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,679.06% | |||
| Profit Margin | -1,693.60% | |||
| Management Effectiveness | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -178.11% | |||
| Return on Equity | -- | |||
| Income Statement | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 750.00K | |||
| Total Revenue (TTM) | 750.00K | |||
| Revenue Per Share | $1.17 | |||
| Gross Profit (TTM) | -6.31M | |||
| EBITDA (TTM) | -12.32M | |||
| EBIT (TTM) | -12.59M | |||
| Net Income (TTM) | -12.70M | |||
| Net Income Avl. to Common (TTM) | -12.70M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 12.03% | |||
| EPS Diluted (TTM) | -26.30 | |||
| EPS Diluted Growth (Q YOY) | 67.31% | |||
| Balance Sheet | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 733.00K | |||
| Cash Per Share (Q) | $1.14 | |||
| Total Current Assets (Q) | 1.20M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -6.24M | |||
| Current Ratio (Q) | 0.157 | |||
| Book Value Per Share (Q) | -$9.71 | |||
| Total Assets (Q) | 2.97M | |||
| Total Current Liabilities (Q) | 7.67M | |||
| Total Debt (Q) | 2.76M | |||
| Total Liabilities (Q) | 9.21M | |||
| Total Common Equity (Q) | -6.24M | |||
| Cash Flow | YTENQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -19.00K | |||
| Cash from Financing (TTM) | 3.98M | |||
| Net Change in Cash (TTM) | -1.86M | |||
| Levered Free Cash Flow (TTM) | -1.74M | |||
| Cash from Operations (TTM) | -5.80M | |||
